| Literature DB >> 29626550 |
Saghi Saghazadeh1, Chiara Rinoldi2, Maik Schot3, Sara Saheb Kashaf4, Fatemeh Sharifi5, Elmira Jalilian6, Kristo Nuutila7, Giorgio Giatsidis7, Pooria Mostafalu1, Hossein Derakhshandeh8, Kan Yue1, Wojciech Swieszkowski9, Adnan Memic10, Ali Tamayol11, Ali Khademhosseini12.
Abstract
Chronic, non-healing wounds place a significant burden on patients and healthcare systems, resulting in impaired mobility, limb amputation, or even death. Chronic wounds result from a disruption in the highly orchestrated cascade of events involved in wound closure. Significant advances in our understanding of the pathophysiology of chronic wounds have resulted in the development of drugs designed to target different aspects of the impaired processes. However, the hostility of the wound environment rich in degradative enzymes and its elevated pH, combined with differences in the time scales of different physiological processes involved in tissue regeneration require the use of effective drug delivery systems. In this review, we will first discuss the pathophysiology of chronic wounds and then the materials used for engineering drug delivery systems. Different passive and active drug delivery systems used in wound care will be reviewed. In addition, the architecture of the delivery platform and its ability to modulate drug delivery are discussed. Emerging technologies and the opportunities for engineering more effective wound care devices are also highlighted.Entities:
Keywords: Drug delivery; Microtechnologies; Nanotechnologies; Transdermal delivery; Wound healing
Mesh:
Substances:
Year: 2018 PMID: 29626550 PMCID: PMC6003879 DOI: 10.1016/j.addr.2018.04.008
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470